Home › Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute
 

Keywords :   


Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute

2015-06-03 06:25:44| drugdiscoveryonline Home Page

Beryllium, a scientific research services company engaging in collaborations with commercial and academic partners, recently announced the development of an MCL-1 platform for structure-guided drug discovery

Tags: the institute drug broad

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »